Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Catalyst Pharm Inc (CPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 295,891
  • Shares Outstanding, K 102,740
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,410 K
  • 36-Month Beta 2.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.12
  • Number of Estimates 5
  • High Estimate -0.08
  • Low Estimate -0.15
  • Prior Year -0.06
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.68 +15.30%
on 11/12/18
3.49 -11.46%
on 10/18/18
-0.38 (-10.95%)
since 10/16/18
3-Month
2.68 +15.30%
on 11/12/18
4.05 -23.70%
on 09/26/18
+0.19 (+6.55%)
since 08/16/18
52-Week
2.18 +41.74%
on 04/04/18
4.51 -31.49%
on 12/01/17
+0.18 (+6.19%)
since 11/16/17

Most Recent Stories

More News
Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update

Catalyst (CPRX) provides pipeline update and the FDA sets action date of Nov 28, 2018 for its lead pipeline candidate, Firdapse during the third quarter of 2018.

MRK : 76.06 (+1.63%)
LLY : 113.83 (+1.45%)
CPRX : 3.09 (+7.29%)
BMY : 54.07 (+1.50%)
Catalyst Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow

CPRX : 3.09 (+7.29%)
Catalyst Pharmaceuticals to Hold Third Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, November 8th, 2018

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.09 (+7.29%)
Market Trends Toward New Normal in AllianceBernstein Holding, Five9, Simpson Manufacturing, Green Plains, Catalyst Pharmaceuticals, and Commercial Vehicle Group -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AllianceBernstein Holding L.P....

AB : 29.65 (-0.34%)
SSD : 57.82 (-0.72%)
CVGI : 6.66 (-2.77%)
FIVN : 42.97 (+0.47%)
CPRX : 3.09 (+7.29%)
GPRE : 17.19 (+1.00%)
Catalyst Pharmaceuticals (CPRX) Catches Eye: Stock Jumps 6.3%

Catalyst Pharmaceuticals (CPRX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

CPRX : 3.09 (+7.29%)
PCRX : 46.80 (-0.99%)
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences

-- Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease on September 25-27 in New York City

CPRX : 3.09 (+7.29%)
Catalyst (CPRX) Up 16% Since Last Earnings Report: Can It Continue?

Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CPRX : 3.09 (+7.29%)
Catalyst Pharmaceuticals to Present at Rodman & Renshaw's 20th Annual Global Investment Conference

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.09 (+7.29%)
Catalyst (CPRX) Posts Narrower-Than-Expected Loss in Q2

The FDA accepts Catalyst's (CPRX) NDA for its lead pipeline candidate, Firdapse, for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) and an action date of Nov 28, 2018 is set for the same.

VRTX : 165.11 (-0.94%)
SGEN : 57.43 (+5.59%)
CPRX : 3.09 (+7.29%)
GLPG : 104.64 (+1.21%)
Catalyst Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Catalyst Pharmaceuticals, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 8:30:00 AM Eastern...

CPRX : 3.09 (+7.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade CPRX with:

Business Summary

CATALYST PHARMACEUTICAL PARTNERS, INC. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for...

See More

Key Turning Points

2nd Resistance Point 3.27
1st Resistance Point 3.18
Last Price 3.09
1st Support Level 2.93
2nd Support Level 2.77

See More

52-Week High 4.51
Fibonacci 61.8% 3.62
Fibonacci 50% 3.35
Last Price 3.09
Fibonacci 38.2% 3.07
52-Week Low 2.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar